Phosphorylation and activation of a transducible recombinant form of human HSP20 in E. coli

Protein based cellular therapeutics have been limited by getting the molecules into cells and the fact that many proteins require post-translational modifications for activation. Protein transduction domains (PTDs), including that from the HIV TAT protein (TAT), are small arginine rich peptides that carry molecules across the cell membrane. We have shown that the heat shock-related protein, HSP20 is a downstream mediator of cyclic nucleotide-dependent relaxation of vascular smooth muscle and is activated by phosphorylation. In this study, we co-expressed in E. coli the cDNAs encoding the catalytic subunit of protein kinase G and a TAT-HSP20 fusion protein composed of the TAT PTD (-YGRKKRRQRRR-) fused to the N-terminus of human HSP20. Immunoblot and HPLC-ESI-MS/MS analysis of the purified TAT-HSP20 demonstrated that it was phosphorylated at serine 40 (equivalent to serine 16 in wild-type human HSP20). This phosphorylated TAT-HSP20 was physiologically active in intact smooth muscles in that it inhibited 5-hydroxytryptamine-induced contractions by 57% ± 4.5. The recombinant phosphorylated protein also led to changes in actin cytoskeletal morphology in 3T3 cells. These results delineate strategies for the expression and activation of therapeutic molecules for intracellular protein based therapeutics.

[1]  J. Kuriyan,et al.  High yield bacterial expression of active c‐Abl and c‐Src tyrosine kinases , 2005, Protein science : a publication of the Protein Society.

[2]  C. Brophy,et al.  Role of the small heat shock proteins in regulating vascular smooth muscle tone. , 2005, Journal of the American College of Surgeons.

[3]  C. Flynn,et al.  Transduction of phosphorylated heat shock-related protein 20, HSP20, prevents vasospasm of human umbilical artery smooth muscle. , 2005, Journal of applied physiology.

[4]  G. Fan,et al.  Novel Cardioprotective Role of a Small Heat-Shock Protein, Hsp20, Against Ischemia/Reperfusion Injury , 2005, Circulation.

[5]  Yuejun Zhen,et al.  Transducible heat shock protein 20 (HSP20) phosphopeptide alters cytoskeletal dynamics , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  C. Flynn,et al.  Transducible recombinant small heat shock-related protein, HSP20, inhibits vasospasm and platelet aggregation. , 2004, Surgery.

[7]  C. Brophy,et al.  Transduction of peptide analogs of the small heat shock-related protein HSP20 inhibits intimal hyperplasia. , 2004, Journal of vascular surgery.

[8]  O. Jensen.  Modification-specific proteomics: characterization of post-translational modifications by mass spectrometry. , 2004, Current opinion in chemical biology.

[9]  C. Flynn,et al.  Transduction of biologically active motifs of the small heat shock‐related protein, HSP20, leads to relaxation of vascular smooth muscle , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  C. Brophy,et al.  The small heat shock protein (HSP) 20 is dynamically associated with the actin cross-linking protein actinin. , 2003, The Journal of surgical research.

[11]  C. Brophy,et al.  Phosphorylation of the heat shock-related protein, HSP20, mediates cyclic nucleotide-dependent relaxation. , 2003, Journal of vascular surgery.

[12]  Hanno Steen,et al.  Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome. , 2002, Trends in biotechnology.

[13]  T. Date,et al.  Expression of unphosphorylated form of human double-stranded RNA-activated protein kinase in Escherichia coli. , 2001, Biochemical and biophysical research communications.

[14]  G. Waksman,et al.  Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo. , 2001, Cancer research.

[15]  C. Rembold,et al.  cGMP‐mediated phosphorylation of heat shock protein 20 may cause smooth muscle relaxation without myosin light chain dephosphorylation in swine carotid artery , 2000, The Journal of physiology.

[16]  H. Rasmussen,et al.  Phosphorylation events associated with cyclic nucleotide-dependent inhibition of smooth muscle contraction. , 1999, The American journal of physiology.

[17]  G. Ramakers,et al.  Regulation of astrocyte morphology by RhoA and lysophosphatidic acid. , 1998, Experimental cell research.

[18]  H. Rasmussen,et al.  Cyclic Nucleotide-dependent Vasorelaxation Is Associated with the Phosphorylation of a Small Heat Shock-related Protein* , 1997, The Journal of Biological Chemistry.

[19]  D. Bossemeyer,et al.  In vivo activation of recombinant cAPK catalytic subunit active site mutants by coexpression of the wild‐type enzyme, evidence for intermolecular cotranslational phosphorylation , 1996, FEBS letters.

[20]  F. Hofmann,et al.  Expression of a chimeric, cGMP‐sensitive regulatory subunit of the cAMP‐depedent protein kinase type Iα , 1995 .

[21]  J. Landry,et al.  Modulation of cellular thermoresistance and actin filament stability accompanies phosphorylation-induced changes in the oligomeric structure of heat shock protein 27 , 1995, Molecular and cellular biology.

[22]  T. Lincoln,et al.  cGMP signaling through cAMP- and cGMP-dependent protein kinases. , 1995, Advances in pharmacology.

[23]  T. Lincoln,et al.  Expression of the catalytic domain of cyclic GMP‐dependent protein kinase in a baculovirus system , 1994, FEBS letters.

[24]  E. Brown,et al.  Expression of recombinant human casein kinase II and recombinant heat shock protein 90 in Escherichia coli and characterization of their interactions. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[25]  F. Hofmann,et al.  Expression of cGMP-dependent protein kinase in Escherichia coli , 1993 .

[26]  R. Fleischmann,et al.  Expression of Chinese hamster cAMP-dependent protein kinase in Escherichia coli results in growth inhibition of bacterial cells: a model system for the rapid screening of mutant type I regulatory subunits. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[27]  S. Taylor,et al.  Expression of the catalytic subunit of cAMP-dependent protein kinase in Escherichia coli: multiple isozymes reflect different phosphorylation states. , 1993, Protein engineering.

[28]  K. Murray,et al.  Cyclic AMP and mechanisms of vasodilation. , 1990, Pharmacology & therapeutics.

[29]  S. Taylor,et al.  Expression of the catalytic subunit of cAMP-dependent protein kinase in Escherichia coli. , 1989, The Journal of biological chemistry.

[30]  A. Means,et al.  Myosin light chain kinase structure function analysis using bacterial expression. , 1989, The Journal of biological chemistry.

[31]  Maurice Green,et al.  Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein , 1988, Cell.

[32]  Carl O. Pabo,et al.  Cellular uptake of the tat protein from human immunodeficiency virus , 1988, Cell.

[33]  F. Hofmann,et al.  A catalytically active fragment of cGMP-dependent protein kinase. Occupation of its cGMP-binding sites does not affect its phosphotransferase activity. , 1987, European journal of biochemistry.